Read + Share
Raval P, Ding Q, Singh P, Alrohaibani A, et al. HER2 status change in residual breast carcinoma after neoadjuvant HER2-targeted
therapy in patients with HER2-positive breast cancer. Breast Cancer Res Treat 2026;219:25.
PMID: 42803995
|
 |
|
Raval P, Ding Q, Singh P, Alrohaibani A, et al. HER2 status change in residual breast carcinoma after neoadjuvant HER2-targeted
therapy in patients with HER2-positive breast cancer. Breast Cancer Res Treat 2026;219:25.
PMID: 42803995
|
|
|
|